Regulatory guidelines (ICH-GCP, FDA/EMA) require one Principal Investigator per site who is ultimately responsible for the trial. You can have two investigators working closely, but only one can be the official PI. The other should be a Sub-Investigator with delegated tasks documented in the site delegation log. This keeps accountability clear and compliant.